Claudio Cantabrana PhD

Dr. Claudio Hidalgo Cantabrana is a founder and Chief Executive Officer of Microviable Therapeutics, and a member of the board. He has led the company since 2021 with a strategic vision focused on the development of novel biological medicines based on commensal bacteria from the microbiota.
Claudio completed his postdoctoral training at NC State University (NC, USA), focused on the discovery of novel CRISPR-Cas systems for genome editing in bacteria.

Previously, Claudio earned his doctorate focused on microbiology, probiotics, and microbial genetics at the University of Oviedo (Spain), performed at IPLA-CSIC (Spanish National Research Council), after an MS in Biotechnology and a BS in Biology. He has worked in several international research organizations across Europe and the USA. Over his scientific career, he has developed and licensed several patents, published numerous scientific manuscripts, and received international fellowships (FEMS, EMBO, FPI) and awards.